Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Wolfgang, Hagmann"'
Autor:
Esther Schamschula, Angelika Lahnsteiner, Yassen Assenov, Wolfgang Hagmann, Nadja Zaborsky, Markus Wiederstein, Anna Strobl, Frauke Stanke, Thomas Muley, Christoph Plass, Burkhard Tümmler, Angela Risch
Publikováno v:
Epigenetics, Vol 17, Iss 8, Pp 837-860 (2022)
Cystic fibrosis (CF) is a monogenic disease, characterized by massive chronic lung inflammation. The observed variability in clinical phenotypes in monozygotic CF twins is likely associated with the extent of inflammation. This study sought to invest
Externí odkaz:
https://doaj.org/article/c7a930fa9d8f4925abc3c509791603ca
Autor:
Thomas Muley, Angelika Lahnsteiner, Anna Strobl, Wolfgang Hagmann, Burkhard Tümmler, Esther Schamschula, Nadja Zaborsky, Christoph Plass, Frauke Stanke, Markus Wiederstein, Yassen Assenov, Angela Risch
Publikováno v:
Epigenetics. 17:837-860
Cystic fibrosis (CF) is a monogenic disease, characterized by massive chronic lung inflammation. The observed variability in clinical phenotypes in monozygotic CF twins is likely associated with the extent of inflammation. This study sought to invest
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 12, Iss 9, Pp 740-747 (2010)
Gemcitabine is widely used as first-line chemotherapeutic drug in the treatment of pancreatic cancer. Our previous experimental chemotherapy studies have shown that treatment of human pancreatic carcinoma cells with 5-fluorouracil (5-FU) alters the c
Externí odkaz:
https://doaj.org/article/3ea2ac64ff4b4e5abbf113a5b013db49
Autor:
Esther, Schamschula, Angelika, Lahnsteiner, Yassen, Assenov, Wolfgang, Hagmann, Nadja, Zaborsky, Markus, Wiederstein, Anna, Strobl, Frauke, Stanke, Thomas, Muley, Christoph, Plass, Burkhard, Tümmler, Angela, Risch
Publikováno v:
Epigenetics. 17(8)
Cystic fibrosis (CF) is a monogenic disease, characterized by massive chronic lung inflammation. The observed variability in clinical phenotypes in monozygotic CF twins is likely associated with the extent of inflammation. This study sought to invest
Autor:
Sabine Riethdorf, Juan Sandoval, Jakob R. Izbicki, Soo-Zin Kim, Faik G. Uzunoglu, Natalia Becker, Dirk Kemming, Harriet Wikman, Katharina E. Effenberger, Manfred Westphal, Wolfgang Hagmann, Manel Esteller, Klaus Pantel, Katrin Lamszus, Michaela Wrage, Angela Risch
Publikováno v:
International Journal of Cancer. 136:2264-2272
For better lung cancer diagnosis and therapy, early detection markers of tumor dissemination are urgently needed, as most lung cancers do not show symptoms until extensive metastasis formation has already taken place. Our previous studies showed that
Autor:
Ralf Jesenofsky, Stephan L. Haas, Cornelius Weidenauer, Wolfgang Hagmann, J.-Matthias Löhr, Ralf Faissner, Rainer Heuchel, Patrick Michl, Marvin Schober
Publikováno v:
Cancers, Vol 6, Iss 4, Pp 2137-2154 (2014)
Cancers
Cancers
Pancreatic ductal adenocarcinoma (PDAC) occurs mainly in people older than 50 years of age. Although great strides have been taken in treating PDAC over the past decades its incidence nearly equals its mortality rate and it was quoted as the 4th lead
Publikováno v:
Cancers
Cancers, Vol 3, Iss 1, Pp 106-125 (2010)
Cancers, Vol 3, Iss 1, Pp 106-125 (2010)
Pancreatic cancer ranks among the tumors most resistant to chemotherapy. Such chemoresistance of tumors can be mediated by various cellular mechanisms including dysregulated apoptosis or ineffective drug concentration at the intracellular target site
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 12, Iss 9, Pp 740-747 (2010)
Gemcitabine is widely used as first-line chemotherapeutic drug in the treatment of pancreatic cancer. Our previous experimental chemotherapy studies have shown that treatment of human pancreatic carcinoma cells with 5-fluorouracil (5-FU) alters the c
Publikováno v:
Pancreatology. 9:136-144
Background: Pancreatic cancer is characterized by high resistance to chemotherapy. Such chemoresistance can be mediated by multidrug resistance proteins (MRPs), breast cancer resistance protein (BCRP), and MDR1 P-glycoprotein. However, the contributi
Autor:
Michaela, Wrage, Wolfgang, Hagmann, Dirk, Kemming, Faik G, Uzunoglu, Sabine, Riethdorf, Katharina, Effenberger, Manfred, Westphal, Katrin, Lamszus, Soo-Zin, Kim, Natalia, Becker, Jakob R, Izbicki, Juan, Sandoval, Manel, Esteller, Klaus, Pantel, Angela, Risch, Harriet, Wikman
Publikováno v:
International journal of cancer. 136(10)
For better lung cancer diagnosis and therapy, early detection markers of tumor dissemination are urgently needed, as most lung cancers do not show symptoms until extensive metastasis formation has already taken place. Our previous studies showed that